4 Programs

Panacea Biotec up 5% as Co begins producing Sputnik V vaccine in India – Business Standard

  1. Panacea Biotec up 5% as Co begins producing Sputnik V vaccine in India  Business Standard
  2. Sputnik single-shot Covid vaccine undergoing final trials: Russian envoy  Mint
  3. ‘Sputnik V vaccine supplies in accordance to contract,’ says Russia  Hindustan Times
  4. Panacea Biotec share rises 5% on Sputnik V vaccine production in India  Business Today
  5. Panacea Biotec share price hits 5% upper circuit on launch of Sputnik V production  Moneycontrol.com
  6. View Full coverage on Google News